SOCS-3 antagonises the proliferative and migratory effects of fibroblast growth factor-2 in prostate cancer by inhibition of p44/p42 MAPK signallingMartin Puhr, Zoran Čulig|Endocrine Related Cancer|2010Cited by 41
Glucocorticoid treatment influences prostate cancer cell growth and the tumor microenvironment via altered glucocorticoid receptor signaling in prostate fibroblastsAndrea Eigentler, Martin Puhr|Oncogene|2023Cited by 19
Inhibition of the Sterol Regulatory Element Binding Protein SREBF-1 Overcomes Docetaxel Resistance in Advanced Prostate CancerMaximilian Peter Brandt, Martin Puhr|American Journal Of Pathology|2024Cited by 3